A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This is A Multi-centre, Single-arm, Prospective, Interventional Study to Assess Efficacy and
Safety of Neoadjuvant Hormone Therapy using Zoladex (Goserelin) and Casodex (Bicalutamide) in
Patients with Advanced Prostate Cancer Undergoing Radical Prostatectomy, to assess the
efficacy by resectability rate of neoadjuvant hormone therapy (NHT) in subjects with advanced
prostate cancer.